Itraconazole in Treating Patients With Biochemically Relapsed Prostate Cancer
Status:
Completed
Trial end date:
2018-09-30
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well itraconazole works in treating patients with
biochemically relapsed prostate cancer. Itraconazole may stop the growth of tumor cells by
blocking some of the enzymes needed for cell growth.